Global Hospital-acquired infections (HAIs) Control Market Research Report 2026(Status and Outlook)

May 2026 | 90 pages | ID: GADD8D6C77E3EN
Bosson Research

Abstracts

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

The global Hospital-acquired infections (HAIs) Control market size was estimated at USD 6041.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 2.90% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Hospital-acquired infections (HAIs) Control market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Hospital-acquired infections (HAIs) Control market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Hospital-acquired infections (HAIs) Control market.

Global Hospital-acquired infections (HAIs) Control Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

• STERIS Corporation
• Advanced Sterilization Products Division
• Hoffmann-La Roche
• Pfizer
• Becton Dickinson

Market Segmentation (by Type)

• Diagnostic techniques
• Dleaning and sterilization
• Treatment

Market Segmentation (by Application)

• General Hospital
• Infectious Disease Hospital

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Hospital-acquired infections (HAIs) Control Market

Overview of the regional outlook of the Hospital-acquired infections (HAIs) Control Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hospital-acquired infections (HAIs) Control Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Hospital-acquired infections (HAIs) Control, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Hospital-acquired infections (HAIs) Control
1.2 Key Market Segments
  1.2.1 Hospital-acquired infections (HAIs) Control Segment by Type
  1.2.2 Hospital-acquired infections (HAIs) Control Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 HOSPITAL-ACQUIRED INFECTIONS (HAIS) CONTROL MARKET OVERVIEW

2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 HOSPITAL-ACQUIRED INFECTIONS (HAIS) CONTROL MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Hospital-acquired infections (HAIs) Control Product Life Cycle
3.3 Global Hospital-acquired infections (HAIs) Control Revenue Market Share by Company (2020-2025)
3.4 Hospital-acquired infections (HAIs) Control Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 Hospital-acquired infections (HAIs) Control Market Competitive Situation and Trends
  3.6.1 Hospital-acquired infections (HAIs) Control Market Concentration Rate
  3.6.2 Global 5 and 10 Largest Hospital-acquired infections (HAIs) Control Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 HOSPITAL-ACQUIRED INFECTIONS (HAIS) CONTROL VALUE CHAIN ANALYSIS

4.1 Hospital-acquired infections (HAIs) Control Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF HOSPITAL-ACQUIRED INFECTIONS (HAIS) CONTROL MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Hospital-acquired infections (HAIs) Control Market Porter's Five Forces Analysis

6 HOSPITAL-ACQUIRED INFECTIONS (HAIS) CONTROL MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hospital-acquired infections (HAIs) Control Market by Type (2020-2025)
6.3 Global Hospital-acquired infections (HAIs) Control Market Size Growth Rate by Type (2021-2025)

7 HOSPITAL-ACQUIRED INFECTIONS (HAIS) CONTROL MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hospital-acquired infections (HAIs) Control Market Size (M USD) by Application (2020-2025)
7.3 Global Hospital-acquired infections (HAIs) Control Market Size Growth Rate by Application (2021-2025)

8 HOSPITAL-ACQUIRED INFECTIONS (HAIS) CONTROL MARKET SEGMENTATION BY REGION

8.1 Global Hospital-acquired infections (HAIs) Control Market Size by Region
  8.1.1 Global Hospital-acquired infections (HAIs) Control Market Size by Region
  8.1.2 Global Hospital-acquired infections (HAIs) Control Market Size Market Share by Region
8.2 North America
  8.2.1 North America Hospital-acquired infections (HAIs) Control Market Size by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Hospital-acquired infections (HAIs) Control Market Size by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Spain
8.4 Asia Pacific
  8.4.1 Asia Pacific Hospital-acquired infections (HAIs) Control Market Size by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Hospital-acquired infections (HAIs) Control Market Size by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Hospital-acquired infections (HAIs) Control Market Size by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 KEY COMPANIES PROFILE

9.1 STERIS Corporation
  9.1.1 STERIS Corporation Basic Information
  9.1.2 STERIS Corporation Hospital-acquired infections (HAIs) Control Product Overview
  9.1.3 STERIS Corporation Hospital-acquired infections (HAIs) Control Product Market Performance
  9.1.4 STERIS Corporation SWOT Analysis
  9.1.5 STERIS Corporation Business Overview
  9.1.6 STERIS Corporation Recent Developments
9.2 Advanced Sterilization Products Division
  9.2.1 Advanced Sterilization Products Division Basic Information
  9.2.2 Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Product Overview
  9.2.3 Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Product Market Performance
  9.2.4 Advanced Sterilization Products Division SWOT Analysis
  9.2.5 Advanced Sterilization Products Division Business Overview
  9.2.6 Advanced Sterilization Products Division Recent Developments
9.3 Hoffmann-La Roche
  9.3.1 Hoffmann-La Roche Basic Information
  9.3.2 Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Product Overview
  9.3.3 Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Product Market Performance
  9.3.4 Hoffmann-La Roche SWOT Analysis
  9.3.5 Hoffmann-La Roche Business Overview
  9.3.6 Hoffmann-La Roche Recent Developments
9.4 Pfizer
  9.4.1 Pfizer Basic Information
  9.4.2 Pfizer Hospital-acquired infections (HAIs) Control Product Overview
  9.4.3 Pfizer Hospital-acquired infections (HAIs) Control Product Market Performance
  9.4.4 Pfizer Business Overview
  9.4.5 Pfizer Recent Developments
9.5 Becton Dickinson
  9.5.1 Becton Dickinson Basic Information
  9.5.2 Becton Dickinson Hospital-acquired infections (HAIs) Control Product Overview
  9.5.3 Becton Dickinson Hospital-acquired infections (HAIs) Control Product Market Performance
  9.5.4 Becton Dickinson Business Overview
  9.5.5 Becton Dickinson Recent Developments

10 HOSPITAL-ACQUIRED INFECTIONS (HAIS) CONTROL MARKET FORECAST BY REGION

10.1 Global Hospital-acquired infections (HAIs) Control Market Size Forecast
10.2 Global Hospital-acquired infections (HAIs) Control Market Forecast by Region
  10.2.1 North America Market Size Forecast by Country
  10.2.2 Europe Hospital-acquired infections (HAIs) Control Market Size Forecast by Country
  10.2.3 Asia Pacific Hospital-acquired infections (HAIs) Control Market Size Forecast by Region
  10.2.4 South America Hospital-acquired infections (HAIs) Control Market Size Forecast by Country
  10.2.5 Middle East and Africa Forecasted Sales of Hospital-acquired infections (HAIs) Control by Country

11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

11.1 Global Hospital-acquired infections (HAIs) Control Market Forecast by Type (2026-2035)
  11.1.1 Global Hospital-acquired infections (HAIs) Control Market Size Forecast by Type (2026-2035)
11.2 Global Hospital-acquired infections (HAIs) Control Market Forecast by Application (2026-2035)
  11.2.1 Global Hospital-acquired infections (HAIs) Control Market Size (M USD) Forecast by Application (2026-2035)

12 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Hospital-acquired infections (HAIs) Control Market Size by Type (M USD)
Table 4. Global Hospital-acquired infections (HAIs) Control Market Size by Application
Table 5. Hospital-acquired infections (HAIs) Control Market Size Comparison by Region (M USD)
Table 6. Global Hospital-acquired infections (HAIs) Control Revenue (M USD) by Company (2020-2025)
Table 7. Global Hospital-acquired infections (HAIs) Control Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital-acquired infections (HAIs) Control as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global Hospital-acquired infections (HAIs) Control Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Hospital-acquired infections (HAIs) Control Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global Hospital-acquired infections (HAIs) Control Market Size by Type (M USD)
Table 22. Global Hospital-acquired infections (HAIs) Control Market Size (M USD) by Type (2020-2025)
Table 23. Global Hospital-acquired infections (HAIs) Control Market Share by Type (2020-2025)
Table 24. Global Hospital-acquired infections (HAIs) Control Market Size Growth Rate by Type (2021-2025)
Table 25. Global Hospital-acquired infections (HAIs) Control Market Size by Application
Table 26. Global Hospital-acquired infections (HAIs) Control Market Size by Application (2020-2025) & (M USD)
Table 27. Global Hospital-acquired infections (HAIs) Control Market Share by Application (2020-2025)
Table 28. Global Hospital-acquired infections (HAIs) Control Market Size Growth Rate by Application (2021-2025)
Table 29. Global Hospital-acquired infections (HAIs) Control Market Size by Region (2020-2025) & (M USD)
Table 30. Global Hospital-acquired infections (HAIs) Control Market Size Market Share by Region (2020-2025)
Table 31. North America Hospital-acquired infections (HAIs) Control Market Size by Country (2020-2025) & (M USD)
Table 32. Europe Hospital-acquired infections (HAIs) Control Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific Hospital-acquired infections (HAIs) Control Market Size by Region (2020-2025) & (M USD)
Table 34. South America Hospital-acquired infections (HAIs) Control Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa Hospital-acquired infections (HAIs) Control Market Size by Region (2020-2025) & (M USD)
Table 36. STERIS Corporation Basic Information
Table 37. STERIS Corporation Hospital-acquired infections (HAIs) Control Product Overview
Table 38. STERIS Corporation Hospital-acquired infections (HAIs) Control Revenue (M USD) and Gross Margin (2020-2025)
Table 39. STERIS Corporation SWOT Analysis
Table 40. STERIS Corporation Business Overview
Table 41. STERIS Corporation Recent Developments
Table 42. Advanced Sterilization Products Division Basic Information
Table 43. Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Product Overview
Table 44. Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Revenue (M USD) and Gross Margin (2020-2025)
Table 45. Advanced Sterilization Products Division SWOT Analysis
Table 46. Advanced Sterilization Products Division Business Overview
Table 47. Advanced Sterilization Products Division Recent Developments
Table 48. Hoffmann-La Roche Basic Information
Table 49. Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Product Overview
Table 50. Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Revenue (M USD) and Gross Margin (2020-2025)
Table 51. Hoffmann-La Roche SWOT Analysis
Table 52. Hoffmann-La Roche Business Overview
Table 53. Hoffmann-La Roche Recent Developments
Table 54. Pfizer Basic Information
Table 55. Pfizer Hospital-acquired infections (HAIs) Control Product Overview
Table 56. Pfizer Hospital-acquired infections (HAIs) Control Revenue (M USD) and Gross Margin (2020-2025)
Table 57. Pfizer Business Overview
Table 58. Pfizer Recent Developments
Table 59. Becton Dickinson Basic Information
Table 60. Becton Dickinson Hospital-acquired infections (HAIs) Control Product Overview
Table 61. Becton Dickinson Hospital-acquired infections (HAIs) Control Revenue (M USD) and Gross Margin (2020-2025)
Table 62. Becton Dickinson Business Overview
Table 63. Becton Dickinson Recent Developments
Table 64. Global Hospital-acquired infections (HAIs) Control Market Size Forecast by Region (2026-2035) & (M USD)
Table 65. North America Hospital-acquired infections (HAIs) Control Market Size Forecast by Country (2026-2035) & (M USD)
Table 66. Europe Hospital-acquired infections (HAIs) Control Market Size Forecast by Country (2026-2035) & (M USD)
Table 67. Asia Pacific Hospital-acquired infections (HAIs) Control Market Size Forecast by Region (2026-2035) & (M USD)
Table 68. South America Hospital-acquired infections (HAIs) Control Market Size Forecast by Country (2026-2035) & (M USD)
Table 69. Middle East and Africa Hospital-acquired infections (HAIs) Control Market Size Forecast by Country (2026-2035) & (M USD)
Table 70. Global Hospital-acquired infections (HAIs) Control Market Size Forecast by Type (2026-2035) & (M USD)
Table 71. Global Hospital-acquired infections (HAIs) Control Market Size Forecast by Application (2026-2035) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Industry Chain of Hospital-acquired infections (HAIs) Control
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hospital-acquired infections (HAIs) Control Market Size (M USD), 2025-2035
Figure 5. Global Hospital-acquired infections (HAIs) Control Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Hospital-acquired infections (HAIs) Control Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Hospital-acquired infections (HAIs) Control Product Life Cycle
Figure 12. Global Hospital-acquired infections (HAIs) Control Revenue Share by Company in 2025
Figure 13. Hospital-acquired infections (HAIs) Control Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Hospital-acquired infections (HAIs) Control Revenue in 2025
Figure 15. Value Chain Map of Hospital-acquired infections (HAIs) Control
Figure 16. Global Hospital-acquired infections (HAIs) Control Market PEST Analysis
Figure 17. Global Hospital-acquired infections (HAIs) Control Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Hospital-acquired infections (HAIs) Control Market Share by Type
Figure 20. Market Share of Hospital-acquired infections (HAIs) Control by Type (2020-2025)
Figure 21. Global Hospital-acquired infections (HAIs) Control Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Hospital-acquired infections (HAIs) Control Market Share by Application
Figure 24. Global Hospital-acquired infections (HAIs) Control Market Share by Application (2020-2025)
Figure 25. Global Hospital-acquired infections (HAIs) Control Market Share by Application in 2024
Figure 26. Global Hospital-acquired infections (HAIs) Control Market Size Growth Rate by Application (2021-2025)
Figure 27. Global Hospital-acquired infections (HAIs) Control Market Size Market Share by Region (2020-2025)
Figure 28. North America Hospital-acquired infections (HAIs) Control Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America Hospital-acquired infections (HAIs) Control Market Size Market Share by Country in 2024
Figure 30. U.S. Hospital-acquired infections (HAIs) Control Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada Hospital-acquired infections (HAIs) Control Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico Hospital-acquired infections (HAIs) Control Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe Hospital-acquired infections (HAIs) Control Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe Hospital-acquired infections (HAIs) Control Market Share by Country in 2024
Figure 35. Germany Hospital-acquired infections (HAIs) Control Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France Hospital-acquired infections (HAIs) Control Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. Hospital-acquired infections (HAIs) Control Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy Hospital-acquired infections (HAIs) Control Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain Hospital-acquired infections (HAIs) Control Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific Hospital-acquired infections (HAIs) Control Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific Hospital-acquired infections (HAIs) Control Market Size Market Share by Region in 2024
Figure 42. China Hospital-acquired infections (HAIs) Control Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan Hospital-acquired infections (HAIs) Control Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea Hospital-acquired infections (HAIs) Control Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India Hospital-acquired infections (HAIs) Control Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia Hospital-acquired infections (HAIs) Control Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America Hospital-acquired infections (HAIs) Control Market Size and Growth Rate (M USD)
Figure 48. South America Hospital-acquired infections (HAIs) Control Market Size Market Share by Country in 2024
Figure 49. Brazil Hospital-acquired infections (HAIs) Control Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina Hospital-acquired infections (HAIs) Control Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia Hospital-acquired infections (HAIs) Control Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa Hospital-acquired infections (HAIs) Control Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa Hospital-acquired infections (HAIs) Control Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia Hospital-acquired infections (HAIs) Control Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE Hospital-acquired infections (HAIs) Control Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt Hospital-acquired infections (HAIs) Control Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria Hospital-acquired infections (HAIs) Control Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa Hospital-acquired infections (HAIs) Control Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global Hospital-acquired infections (HAIs) Control Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global Hospital-acquired infections (HAIs) Control Market Share Forecast by Type (2026-2035)
Figure 61. Global Hospital-acquired infections (HAIs) Control Market Share Forecast by Application (2026-2035)